News

Serum Institute’s partner NeuClone develops mAb for breast cancer indication

NeuClone's Perjeta (pertuzumab) biosimilar is partnered with Serum Institute of India (Serum). Under the partnership, NeuClone and Serum are developing ten biosimilars for global markets.

Dec 18, 2018

By : By Team ABLE

DBT calls for proposals to establish Biotech-KISAN Hubs

This special Call for Proposals is for establishing Biotech-KISAN Hubs in four agro-climatic zones in the country.

Dec 18, 2018

By : By Team ABLE

Prime Minister Narendra Modi inaugurates the Partners Forum - 2018

Prime Minister Narendra Modi inaugurated the Partners’ Forum, 2018, in New Delhi on December 12th. He also released the coffee table book ‘Proven Paths’, a compendium of 36 best practices in maternal, child and adolescent health, at the inaugural ceremony.

Dec 13, 2018

By : Team Able

PerkinElmer promotes Prahlad Singh to lead newly created role

Dr. Singh, along with the leaders of the Company’s corporate functions, will continue to report to Robert F. Friel, PerkinElmer’s Chairman and Chief Executive Officer.

Dec 11, 2018

By : Team ABLE

DBT organizes XII Indian MedTech Summit

This annual event is organized by DBT under its flagship program-School of International Biodesign implemented at AIIMS and IITD in collaboration with International Partners with techno-legal management by BCIL.

Dec 10, 2018

By : Team ABLE